{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:01:06Z","timestamp":1793239266330,"version":"4.5.0"},"reference-count":139,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.semnephrol.2012.12.015","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T15:30:12Z","timestamp":1362583812000},"page":"143-157","source":"Crossref","is-referenced-by-count":36,"title":["Insights From Genetic Disorders of Phosphate Homeostasis"],"prefix":"10.1016","volume":"33","author":[{"given":"Marta","family":"Christov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"J\u00fcppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2012.12.015_bib1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2265.2010.03919.x","article-title":"Mutational analysis of PHEX, FGF23 and DMP1 in a cohort of patients with hypophosphatemic rickets","volume":"74","author":"Ruppe","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","author":"White","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib3","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1210\/jc.86.2.497","article-title":"The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting","volume":"86","author":"White","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","article-title":"Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice","volume":"23","author":"Sitara","year":"2004","journal-title":"Matrix Biol"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib7","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","article-title":"Pathogenic role of Fgf23 in Hyp mice","volume":"291","author":"Liu","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib8","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/me.2010-0142","article-title":"Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse","volume":"24","author":"Fon Tacer","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib9","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/en.143.8.3179","article-title":"Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo","volume":"143","author":"Shimada","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bone.2004.04.002","article-title":"FGF23 is processed by proprotein convertases but not by PHEX","volume":"35","author":"Benet-Pages","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/jbmr.1738","article-title":"Hexa-D-arginine treatment increases 7B2-PC2 activity in hyp-mouse osteoblasts and rescues the HYP phenotype","volume":"28","author":"Yuan","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.0902006107","article-title":"Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation","volume":"107","author":"Goetz","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","article-title":"Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women","volume":"21","author":"Burnett","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib14","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1359\/jbmr.090406","article-title":"Effects of hPTH(1-34) infusion on circulating serum phosphate, 1,25-dihydroxyvitamin D, and FGF23 levels in healthy men","volume":"24","author":"Burnett-Bowie","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib15","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/jc.2006-0021","article-title":"Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men","volume":"91","author":"Antoniucci","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib16","doi-asserted-by":"crossref","first-page":"c74","DOI":"10.1159\/000319650","article-title":"Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate","volume":"117","author":"Cancela","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jsbmb.2006.12.054","article-title":"1,25-Dihydroxyvitamin D3\/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism","volume":"103","author":"Barthel","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib18","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.bone.2011.06.025","article-title":"Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo","volume":"49","author":"Rhee","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib19","doi-asserted-by":"crossref","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","article-title":"PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop","volume":"299","author":"Lavi-Moshayoff","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2215\/CJN.06240611","article-title":"(1-34) Parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers","volume":"7","author":"Gutierrez","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib21","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/ng1868","article-title":"DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis","volume":"38","author":"Lorenz-Depiereux","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib22","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","article-title":"Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism","volume":"38","author":"Feng","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib23","doi-asserted-by":"crossref","first-page":"E254","DOI":"10.1152\/ajpendo.90201.2008","article-title":"Pathogenic role of Fgf23 in Dmp1-null mice","volume":"295","author":"Liu","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jbmr.226","article-title":"The biological function of DMP-1 in osteocyte maturation is mediated by its 57-kDa C-terminal fragment","volume":"26","author":"Lu","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib25","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib26","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1096\/fj.10-177816","article-title":"Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling","volume":"25","author":"Martin","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib27","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1002\/jbmr.478","article-title":"FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone","volume":"26","author":"Wohrle","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib28","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1210\/jc.2011-1239","article-title":"Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans","volume":"96","author":"Imel","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib29","doi-asserted-by":"crossref","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","article-title":"Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice","volume":"108","author":"Farrow","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib30","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/jbmr.1546","article-title":"Mechanism of FGF23 processing in fibrous dysplasia","volume":"27","author":"Bhattacharyya","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib31","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1210\/en.2005-0670","article-title":"Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23","volume":"146","author":"Yu","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib32","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib34","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib35","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1677\/JOE-10-0181","article-title":"Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation","volume":"207","author":"Farrow","year":"2010","journal-title":"J Endocrinol"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib37","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00424-003-1084-1","article-title":"Effect of hydrolysis-resistant FGF23-R179Q on dietary phosphate regulation of the renal type-II Na\/Pi transporter","volume":"446","author":"Segawa","year":"2003","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib38","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1210\/en.2004-0233","article-title":"Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders","volume":"145","author":"Bai","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib40","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI118224","article-title":"Parathyroid cell proliferation in normal and chronic renal failure rats","volume":"96","author":"Naveh-Many","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib41","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1073\/pnas.89.17.8097","article-title":"Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3","volume":"89","author":"Demay","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib42","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1681\/ASN.V9101845","article-title":"High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro","volume":"9","author":"Almaden","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib43","series-title":"Endocrinology","first-page":"1136","article-title":"Calcium regulation, calcium homeostasis, and genetic disorders of calcium metabolism","author":"Thakker","year":"2010"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib44","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.1658941","article-title":"A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide","volume":"254","author":"J\u00fcppner","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib45","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/sj.ki.5001813","article-title":"Proximal tubular handling of phosphate: a molecular perspective","volume":"70","author":"Forster","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib46","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa1012717","article-title":"Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance","volume":"364","author":"Linglart","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/jc.2008-0220","article-title":"Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia","volume":"94","author":"Brown","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib48","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1359\/jbmr.2001.16.5.806","article-title":"Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia","volume":"16","author":"Collins","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000083895","article-title":"GNAS locus and pseudohypoparathyroidism","volume":"63","author":"Bastepe","year":"2005","journal-title":"Horm Res"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib50","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1210\/en.2007-0243","article-title":"Early lethality in Hyp mice with targeted deletion of Pth gene","volume":"148","author":"Bai","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib51","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","article-title":"Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23","volume":"61","author":"Bergwitz","year":"2010","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib52","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1210\/jc.2004-0724","article-title":"FGF-23 is elevated by chronic hyperphosphatemia","volume":"89","author":"Gupta","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib53","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1507\/endocrj.K06-156","article-title":"Fibroblast growth factor-23 (FGF23) in patients with transient hypoparathyroidism: its important role in serum phosphate regulation","volume":"54","author":"Yamashita","year":"2007","journal-title":"Endocr J"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib54","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/jbmr.433","article-title":"FGF-23\/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH","volume":"26","author":"Yuan","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib55","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"10.1016\/j.semnephrol.2012.12.015_bib56","first-page":"S57","article-title":"The vitamin D hormone and its nuclear receptor: molecular actions and disease states","volume":"154","author":"Haussler","year":"1997","journal-title":"J Endocrinol"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib57","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1126\/science.2849209","article-title":"Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets","volume":"242","author":"Hughes","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib58","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1113\/expphysiol.2005.032516","article-title":"Intestinal phosphate absorption and the effect of vitamin D: a comparison of rats with mice","volume":"91","author":"Marks","year":"2006","journal-title":"Exp Physiol"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib59","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1681\/ASN.2009050559","article-title":"Intestinal npt2b plays a major role in phosphate absorption and homeostasis","volume":"20","author":"Sabbagh","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib60","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/BJ20041799","article-title":"Role of the vitamin D receptor in FGF23 action on phosphate metabolism","volume":"390","author":"Inoue","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib61","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/geno.2000.6235","article-title":"MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia","volume":"67","author":"Rowe","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib62","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1359\/jbmr.2002.17.6.1102","article-title":"Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism","volume":"17","author":"DeBeur","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib63","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1210\/jc.2004-0357","article-title":"Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors","volume":"90","author":"Carpenter","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib64","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1074\/jbc.M203250200","article-title":"Targeted disruption of the osteoblast\/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass","volume":"278","author":"Gowen","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib65","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1210\/en.2010-1351","article-title":"Genetic ablation of sfrp4 in mice does not affect serum phosphate homeostasis","volume":"152","author":"Christov","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000093277","article-title":"FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation","volume":"104","author":"Pande","year":"2006","journal-title":"Nephron Physiol"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib67","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bone.2009.08.008","article-title":"Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease","volume":"45","author":"Pereira","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib68","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1210\/jcem-60-6-1093","article-title":"Genetic transmission of tumoral calcinosis: autosomal dominant with variable clinical expressivity","volume":"60","author":"Lyles","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib69","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1358","article-title":"Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis","volume":"36","author":"Topaz","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib70","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1210\/jc.2006-1247","article-title":"Tumoral calcinosis presenting with eyelid calcifications due to novel missense mutations in the glycosyl transferase domain of the GALNT3 gene","volume":"91","author":"Ichikawa","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib71","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1210\/jc.2004-2238","article-title":"A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis","volume":"90","author":"Larsson","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib72","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","article-title":"An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia","volume":"14","author":"Benet-Pages","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib73","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1210\/jc.2009-0961","article-title":"Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis","volume":"94","author":"Bergwitz","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib74","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0022-3476(70)80081-6","article-title":"Cortical hyperostosis with hyperphosphatemia: a new syndrome?","volume":"77","author":"Melhem","year":"1970","journal-title":"J Pediatr"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib75","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00109-004-0610-8","article-title":"Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders","volume":"83","author":"Frishberg","year":"2005","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib76","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1172\/JCI31330","article-title":"A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis","volume":"117","author":"Ichikawa","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib77","first-page":"1136","article-title":"Calcium regulation, calcium homeostasis, and genetic disorders of calcium metabolism","volume":"Vol 1","author":"Thakker","year":"2010"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib78","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-0-387-77576-0_3","article-title":"The GNAS locus and pseudohypoparathyroidism","volume":"626","author":"Bastepe","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib79","doi-asserted-by":"crossref","first-page":"8715","DOI":"10.1073\/pnas.95.15.8715","article-title":"Variable and tissue-specific hormone resistance in heterotrimeric Gs protein alpha-subunit (Gsalpha) knockout mice is due to tissue-specific imprinting of the gsalpha gene","volume":"95","author":"Yu","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib80","doi-asserted-by":"crossref","first-page":"11798","DOI":"10.1073\/pnas.95.20.11798","article-title":"The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3","volume":"95","author":"J\u00fcppner","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib81","doi-asserted-by":"crossref","first-page":"E268","DOI":"10.1210\/jc.2011-1972","article-title":"Genetic defect in CYP24A1, the vitamin D 24-hydroxylase gene, in a patient with severe infantile hypercalcemia","volume":"97","author":"Dauber","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib82","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJMoa1103864","article-title":"Mutations in CYP24A1 and idiopathic infantile hypercalcemia","volume":"365","author":"Schlingmann","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib83","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1095-130","article-title":"A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP consortium","volume":"11","author":"Francis","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib84","first-page":"790","article-title":"Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets","volume":"60","author":"Holm","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib85","doi-asserted-by":"crossref","first-page":"37419","DOI":"10.1074\/jbc.M304544200","article-title":"Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX","volume":"278","author":"Liu","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib86","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib87","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1359\/jbmr.080417","article-title":"Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23","volume":"23","author":"Yamazaki","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib88","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1359\/jbmr.080601","article-title":"MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM","volume":"23","author":"Addison","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib89","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1359\/jbmr.090832","article-title":"Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage","volume":"25","author":"Addison","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib90","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1677\/joe.1.07059","article-title":"Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity","volume":"192","author":"Liu","year":"2007","journal-title":"J Endocrinol"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib91","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1302\/0301-620X.60B3.681423","article-title":"Hereditary hypophosphataemic rickets with autosomal recessive inheritance and severe osteosclerosis","volume":"60B","author":"Perry","year":"1978","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib92","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000151727","article-title":"Studies of the DMP1 57-kDa functional domain both in vivo and in vitro","volume":"189","author":"Lu","year":"2009","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib93","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.1074\/jbc.M412911200","article-title":"Dmp1-deficient mice display severe defects in cartilage formation responsible for a chondrodysplasia-like phenotype","volume":"280","author":"Ye","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib94","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajhg.2010.01.006","article-title":"Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets","volume":"86","author":"Lorenz-Depiereux","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib95","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajhg.2010.01.010","article-title":"Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene","volume":"86","author":"Levy-Litan","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib96","doi-asserted-by":"crossref","first-page":"e32177","DOI":"10.1371\/journal.pone.0032177","article-title":"Altered bone development and an increase in FGF-23 expression in Enpp1(\u2212\/\u2212) mice","volume":"7","author":"Mackenzie","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib97","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ajhg.2011.11.020","article-title":"Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6","volume":"90","author":"Nitschke","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib98","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.lfs.2005.09.052","article-title":"Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia","volume":"78","author":"Kobayashi","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib99","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-induced osteomalacia","volume":"18","author":"Chong","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib100","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S8756-3282(01)00586-5","article-title":"A case of neuroendocrine oncogenic osteomalacia associated with a PHEX and fibroblast growth factor-23 expressing sinusidal malignant schwannoma","volume":"29","author":"John","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib101","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1210\/jc.2005-2105","article-title":"Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia","volume":"91","author":"Imel","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib102","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa020028","article-title":"Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter","volume":"347","author":"Prie","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib103","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1359\/jbmr.2003.18.12.2135","article-title":"Functional characterization of two naturally occurring mutations in the human sodium-phosphate cotransporter type IIa","volume":"18","author":"Virkki","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib104","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1056\/NEJMoa0905647","article-title":"A loss-of-function mutation in NaPi-IIa and renal Fanconi's syndrome","volume":"362","author":"Magen","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib105","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJM198503073121003","article-title":"Hereditary hypophosphatemic rickets with hypercalciuria","volume":"312","author":"Tieder","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib106","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1086\/499409","article-title":"SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis","volume":"78","author":"Bergwitz","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib107","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1210\/jc.2005-2840","article-title":"Intronic deletions in the SLC34A3 gene cause hereditary hypophosphatemic rickets with hypercalciuria","volume":"91","author":"Ichikawa","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib108","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/499410","article-title":"Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3","volume":"78","author":"Lorenz-Depiereux","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib109","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1002\/jps.22614","article-title":"Sodium-dependent phosphate cotransporters: lessons from gene knockout and mutation studies","volume":"100","author":"Miyamoto","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib110","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1006\/bbrc.1999.0666","article-title":"Cloning and functional characterization of a sodium-dependent phosphate transporter expressed in human lung and small intestine","volume":"258","author":"Feild","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib111","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bbrc.2009.02.067","article-title":"Targeted deletion of the tybe IIb Na(+)-dependent Pi-co-transporter, NaPi-IIb, results in early embryonic lethality","volume":"381","author":"Shibasaki","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib112","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/508263","article-title":"Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis","volume":"79","author":"Corut","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib113","first-page":"452","article-title":"[An unusual form of primary vitamin D-resistant rickets with hypocalcemia and autosomal-dominant hereditary transmission: hereditary pseudo-deficiency rickets]","volume":"16","author":"Prader","year":"1961","journal-title":"Helv Paediatr Acta"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib114","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJM197310182891601","article-title":"Pathogenesis of hereditary vitamin-D-dependent rickets","volume":"289","author":"Fraser","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib115","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1359\/jbmr.1997.12.10.1552","article-title":"The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus","volume":"12","author":"St-Arnaud","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib116","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1210\/me.11.13.1961","article-title":"Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1","volume":"11","author":"Fu","year":"1997","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib117","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJM199803053381004","article-title":"Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets","volume":"338","author":"Kitanaka","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib118","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1210\/jc.87.6.2424","article-title":"Novel gene mutations in patients with 1alpha-hydroxylase deficiency that confer partial enzyme activity in vitro","volume":"87","author":"Wang","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib119","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1056\/NEJM197805042981804","article-title":"Vitamin-D-dependent rickets type II","volume":"298","author":"Brooks","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib120","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1210\/jcem-50-5-927","article-title":"Adult-onset vitamin D-resistant osteomalacia with the unresponsiveness to parathyroid hormone","volume":"50","author":"Fujita","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib121","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/379445a0","article-title":"A common molecular basis for three inherited kidney stone diseases","volume":"379","author":"Lloyd","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib122","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1523-1755.1998.00718.x","article-title":"X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations","volume":"53","author":"Scheinman","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib123","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/hmg\/2.4.461","article-title":"Nonsense mutations in the OCRL-1 gene in patients with the oculocerebrorenal syndrome of Lowe","volume":"2","author":"Leahey","year":"1993","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib124","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ng1197-324","article-title":"Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome","volume":"17","author":"Santer","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib125","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/427956","article-title":"Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation","volume":"76","author":"White","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib126","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ajmg.a.30599","article-title":"Elevated fibroblast growth factor-23 in hypophosphatemic linear nevus sebaceous syndrome","volume":"134","author":"Hoffman","year":"2005","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib127","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ajmg.a.30915","article-title":"Skeletal changes in epidermal nevus syndrome: does focal bone disease harbor clues concerning pathogenesis?","volume":"139A","author":"Heike","year":"2005","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib128","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1359\/jbmr.090509","article-title":"Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets\/osteomalacia","volume":"24","author":"Aono","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib129","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.2010.313","article-title":"Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease","volume":"78","author":"Hasegawa","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib130","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib131","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1258\/000456307781646102","article-title":"The association of circulating ferritin with serum concentrations of fibroblast growth factor-23 measured by three commercial assays","volume":"44","author":"Durham","year":"2007","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib132","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1210\/jc.2009-1603","article-title":"Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active","volume":"95","author":"Shimada","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib133","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib134","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1096\/fj.10-154765","article-title":"Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule","volume":"24","author":"Hu","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib135","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1073\/pnas.0712361105","article-title":"A translocation causing increased alpha-klotho level results in hypophosphatemic rickets and hyperparathyroidism","volume":"105","author":"Brownstein","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib136","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib137","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.bone.2008.07.250","article-title":"Differential effects of intermittent PTH(1-34) and PTH(7-34) on bone microarchitecture and aortic calcification in experimental renal failure","volume":"43","author":"Sebastian","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib138","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1525-139X.2010.00817.x","article-title":"Reducing the risk of re-fracture in the dialysis population: is it time to consider therapy with PTH analogues?","volume":"24","author":"Jamal","year":"2011","journal-title":"Semin Dial"},{"key":"10.1016\/j.semnephrol.2012.12.015_bib139","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jsbmb.2010.03.065","article-title":"Vitamin D analogues targeting CYP24 in chronic kidney disease","volume":"121","author":"Posner","year":"2010","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027092951200277X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027092951200277X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T23:06:50Z","timestamp":1715036810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027092951200277X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":139,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S027092951200277X"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2012.12.015","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}